Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03810105 |
|---|---|
| Brief Title: | A Study of Olaparib and Durvalumab in Prostate Cancer |
| First Submitted : | January 17, 2019 |
| First Submitted that Met QC Criteria : | January 17, 2019 |
| First Posted : | January 18, 2019 |
| Last Update Submitted that Met QC Criteria : | March 30, 2022 |
| Last Update Posted : | March 31, 2022 |